1. Liu S, Xiang Y, Wang B, Gao C, Chen Z, Xie S, Wu J, Liu Y, Zhao X, Yang C, Yue Z, Wang L, Wen X, Zhang R, Zhang F, Xu H, Zhai X, Zheng H, Zhang H, Qian M.USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis.Blood Advances.2023.7(13).3099-3112.SCI |
2. Fei-Fei Yang , Tian-Lin Xue , Chao Gao , Ying Wu, Wei Lin , Jun Li , Rui-Dong Zhang, Hu-Yong Zheng, Shu-Guang Liu *.Effects of SLCO1B1 on elimination and toxicities of high-dose methotrexate in pediatric acute lymphoblastic leukemia.Pharmacogenomics .2022.23(15).821-834.SCI |
3. Shuguang Liu, Chao Gao, Ying Wu, Wei Lin, Jun Li, Tianlin Xue, Linya Wang, Huyong Zheng, Ruidong Zhang*.HLA-DRB1*16:02 is associated with PEG-asparaginase hypersensitivity.Pharmacogenomics.2021.22(17).1135–1142.SCI |
4. Shu‑Guang Liu* , Zhi‑Xia Yue, Zhi‑Gang Li, Rui‑Dong Zhang, Hu‑Yong Zheng, Xiao‑Xi Zhao and Chao Gao*.β‑catenin promotes MTX resistance of leukemia cells by down.regulating FPGS expression via NF‑κB.Cancer Cell International.2020.20(271).1-8.SCI |
5. Takaya Moriyama#, Shuguang Liu#, Jing Li, Julia Meyer, Xujie Zhao,Wentao Yang, Youming Shao, Richard Heath, Ales Hnízda,William L. Carroll, Jun J.Yang*.Mechanisms of NT5C2-Mediated Thiopurine Resistance in Acute Lymphoblastic Leukemia.Molecular Cancer Therapeutics.2019.18(10).1887-1895.SCI |
6. Chao Gao#, Shu‑Guang Liu#, Zhi‑Xia Yue, Yi Liu, Jing Liang, Jun Li, Yuan‑Yuan Zhang, Jiao‑Le Yu, Ying Wu,Wei Lin, Hu‑Yong Zheng and Rui‑Dong Zhang*.Clinical‑biological characteristics and treatment outcomes of pediatric pro‑B ALL patients enrolled in BCH‑2003 and CCLG‑2008 protocol: a study of 121 Chinese children.Cancer Cell International.2019.19(293).1-9.SCI |